Liver histology of an afibrinogenemic patient with the Bβ-L353R mutation showing no evidence of hepatic endoplasmic reticulum storage disease (ERSD); comparative study in COS-1 cells of the intracellular processing of the Bβ-L353R fibrinogen vs. the ERSD-associated γ-G284R mutant

S. Duga, P. Braidotti, R. Asselta, M. Maggioni, E. Santagostino, C. Pellegrini, G. Coggi, M. Malcovati, Maria Luisa Tenchini

Research output: Contribution to journalArticle

Abstract

Background. Type I fibrinogen deficiencies (hypofibrinogenemia and afibrinogenemia) are rare congenital disorders characterized by low or unmeasurable plasma fibrinogen antigen levels. Their genetic bases are represented by mutations within the three fibrinogen genes. Among the 11 reported missense mutations, a few have been characterized by expression studies and found to have an impaired fibrinogen assembly and/or secretion. Histopathological analyses were previously reported in two hypofibrinogenemic cases with discernible hepatic disease, revealing that both underlying mutations (γ-Gly284Arg and γ-Arg375Trp) were associated with hepatic fibrinogen endoplasmic reticulum storage disease (ERSD). Objective: The objective of this study was to investigate the liver histology in an afibrinogenemic patient, homozygous for the Bβ-Leu353Arg mutation, and to study the intracellular processing of the mutant protein. Patients and methods: Liver histology was evaluated by light microscopy, electron microscopy and immunocytochemistry. Intracellular processing of mutant fibrinogen was analyzed by pulse-chase labeling and immunoprecipitation experiments. Messenger RNA levels were determined by real-time reverse transcription-polymerase chain reaction (RT-PCR). Results: The histopathological characterization of the liver showed no signs of fibrinogen accumulation, a difference from the previously reported findings in two hypofibrinogenemic kindreds with ERSD. To evaluate whether the Bβ-Leu353Arg mutation and the ERSD-associated γ-Gly284Arg mutation affected intracellular fibrinogen trafficking differently, both mutant proteins were expressed in COS-1 cells. Bβ-Leu353Arg led to a more severe secretion defect, but no differences that could explain phenotype-genotype correlation were found in the intracellular processing. Endoglycosidase-H analysis demonstrated a secretion block before translocation to the Golgi medial stacks. Real-time RT-PCR studies showed normal levels of the Bβ mRNA in the patient's liver. Conclusions: The results confirm that Bβ-Leu353Arg is associated with impaired fibrinogen secretion, but not with hepatic ERSD.

Original languageEnglish
Pages (from-to)724-732
Number of pages9
JournalJournal of Thrombosis and Haemostasis
Volume3
Issue number4
DOIs
Publication statusPublished - Apr 2005

Fingerprint

COS Cells
Endoplasmic Reticulum
Fibrinogen
Histology
Mutation
Liver
Afibrinogenemia
Mutant Proteins
Reverse Transcription
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Polymerase Chain Reaction
Messenger RNA
Glycoside Hydrolases
Genetic Association Studies
Missense Mutation
Immunoprecipitation
Microscopy
Electron Microscopy
Immunohistochemistry
Light

Keywords

  • Congenital afibrinogenemia
  • Endoplasmic reticulum storage disease
  • Liver histopathology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{fa8ba0b466f348b58e640a78b02e3ce3,
title = "Liver histology of an afibrinogenemic patient with the Bβ-L353R mutation showing no evidence of hepatic endoplasmic reticulum storage disease (ERSD); comparative study in COS-1 cells of the intracellular processing of the Bβ-L353R fibrinogen vs. the ERSD-associated γ-G284R mutant",
abstract = "Background. Type I fibrinogen deficiencies (hypofibrinogenemia and afibrinogenemia) are rare congenital disorders characterized by low or unmeasurable plasma fibrinogen antigen levels. Their genetic bases are represented by mutations within the three fibrinogen genes. Among the 11 reported missense mutations, a few have been characterized by expression studies and found to have an impaired fibrinogen assembly and/or secretion. Histopathological analyses were previously reported in two hypofibrinogenemic cases with discernible hepatic disease, revealing that both underlying mutations (γ-Gly284Arg and γ-Arg375Trp) were associated with hepatic fibrinogen endoplasmic reticulum storage disease (ERSD). Objective: The objective of this study was to investigate the liver histology in an afibrinogenemic patient, homozygous for the Bβ-Leu353Arg mutation, and to study the intracellular processing of the mutant protein. Patients and methods: Liver histology was evaluated by light microscopy, electron microscopy and immunocytochemistry. Intracellular processing of mutant fibrinogen was analyzed by pulse-chase labeling and immunoprecipitation experiments. Messenger RNA levels were determined by real-time reverse transcription-polymerase chain reaction (RT-PCR). Results: The histopathological characterization of the liver showed no signs of fibrinogen accumulation, a difference from the previously reported findings in two hypofibrinogenemic kindreds with ERSD. To evaluate whether the Bβ-Leu353Arg mutation and the ERSD-associated γ-Gly284Arg mutation affected intracellular fibrinogen trafficking differently, both mutant proteins were expressed in COS-1 cells. Bβ-Leu353Arg led to a more severe secretion defect, but no differences that could explain phenotype-genotype correlation were found in the intracellular processing. Endoglycosidase-H analysis demonstrated a secretion block before translocation to the Golgi medial stacks. Real-time RT-PCR studies showed normal levels of the Bβ mRNA in the patient's liver. Conclusions: The results confirm that Bβ-Leu353Arg is associated with impaired fibrinogen secretion, but not with hepatic ERSD.",
keywords = "Congenital afibrinogenemia, Endoplasmic reticulum storage disease, Liver histopathology",
author = "S. Duga and P. Braidotti and R. Asselta and M. Maggioni and E. Santagostino and C. Pellegrini and G. Coggi and M. Malcovati and Tenchini, {Maria Luisa}",
year = "2005",
month = "4",
doi = "10.1111/j.1538-7836.2005.01229.x",
language = "English",
volume = "3",
pages = "724--732",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Liver histology of an afibrinogenemic patient with the Bβ-L353R mutation showing no evidence of hepatic endoplasmic reticulum storage disease (ERSD); comparative study in COS-1 cells of the intracellular processing of the Bβ-L353R fibrinogen vs. the ERSD-associated γ-G284R mutant

AU - Duga, S.

AU - Braidotti, P.

AU - Asselta, R.

AU - Maggioni, M.

AU - Santagostino, E.

AU - Pellegrini, C.

AU - Coggi, G.

AU - Malcovati, M.

AU - Tenchini, Maria Luisa

PY - 2005/4

Y1 - 2005/4

N2 - Background. Type I fibrinogen deficiencies (hypofibrinogenemia and afibrinogenemia) are rare congenital disorders characterized by low or unmeasurable plasma fibrinogen antigen levels. Their genetic bases are represented by mutations within the three fibrinogen genes. Among the 11 reported missense mutations, a few have been characterized by expression studies and found to have an impaired fibrinogen assembly and/or secretion. Histopathological analyses were previously reported in two hypofibrinogenemic cases with discernible hepatic disease, revealing that both underlying mutations (γ-Gly284Arg and γ-Arg375Trp) were associated with hepatic fibrinogen endoplasmic reticulum storage disease (ERSD). Objective: The objective of this study was to investigate the liver histology in an afibrinogenemic patient, homozygous for the Bβ-Leu353Arg mutation, and to study the intracellular processing of the mutant protein. Patients and methods: Liver histology was evaluated by light microscopy, electron microscopy and immunocytochemistry. Intracellular processing of mutant fibrinogen was analyzed by pulse-chase labeling and immunoprecipitation experiments. Messenger RNA levels were determined by real-time reverse transcription-polymerase chain reaction (RT-PCR). Results: The histopathological characterization of the liver showed no signs of fibrinogen accumulation, a difference from the previously reported findings in two hypofibrinogenemic kindreds with ERSD. To evaluate whether the Bβ-Leu353Arg mutation and the ERSD-associated γ-Gly284Arg mutation affected intracellular fibrinogen trafficking differently, both mutant proteins were expressed in COS-1 cells. Bβ-Leu353Arg led to a more severe secretion defect, but no differences that could explain phenotype-genotype correlation were found in the intracellular processing. Endoglycosidase-H analysis demonstrated a secretion block before translocation to the Golgi medial stacks. Real-time RT-PCR studies showed normal levels of the Bβ mRNA in the patient's liver. Conclusions: The results confirm that Bβ-Leu353Arg is associated with impaired fibrinogen secretion, but not with hepatic ERSD.

AB - Background. Type I fibrinogen deficiencies (hypofibrinogenemia and afibrinogenemia) are rare congenital disorders characterized by low or unmeasurable plasma fibrinogen antigen levels. Their genetic bases are represented by mutations within the three fibrinogen genes. Among the 11 reported missense mutations, a few have been characterized by expression studies and found to have an impaired fibrinogen assembly and/or secretion. Histopathological analyses were previously reported in two hypofibrinogenemic cases with discernible hepatic disease, revealing that both underlying mutations (γ-Gly284Arg and γ-Arg375Trp) were associated with hepatic fibrinogen endoplasmic reticulum storage disease (ERSD). Objective: The objective of this study was to investigate the liver histology in an afibrinogenemic patient, homozygous for the Bβ-Leu353Arg mutation, and to study the intracellular processing of the mutant protein. Patients and methods: Liver histology was evaluated by light microscopy, electron microscopy and immunocytochemistry. Intracellular processing of mutant fibrinogen was analyzed by pulse-chase labeling and immunoprecipitation experiments. Messenger RNA levels were determined by real-time reverse transcription-polymerase chain reaction (RT-PCR). Results: The histopathological characterization of the liver showed no signs of fibrinogen accumulation, a difference from the previously reported findings in two hypofibrinogenemic kindreds with ERSD. To evaluate whether the Bβ-Leu353Arg mutation and the ERSD-associated γ-Gly284Arg mutation affected intracellular fibrinogen trafficking differently, both mutant proteins were expressed in COS-1 cells. Bβ-Leu353Arg led to a more severe secretion defect, but no differences that could explain phenotype-genotype correlation were found in the intracellular processing. Endoglycosidase-H analysis demonstrated a secretion block before translocation to the Golgi medial stacks. Real-time RT-PCR studies showed normal levels of the Bβ mRNA in the patient's liver. Conclusions: The results confirm that Bβ-Leu353Arg is associated with impaired fibrinogen secretion, but not with hepatic ERSD.

KW - Congenital afibrinogenemia

KW - Endoplasmic reticulum storage disease

KW - Liver histopathology

UR - http://www.scopus.com/inward/record.url?scp=23044507657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044507657&partnerID=8YFLogxK

U2 - 10.1111/j.1538-7836.2005.01229.x

DO - 10.1111/j.1538-7836.2005.01229.x

M3 - Article

C2 - 15842357

AN - SCOPUS:23044507657

VL - 3

SP - 724

EP - 732

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - 4

ER -